Two powerhouse medical device companies reported significant developments in their cardiovascular stent programs in mid-July, with an emphasis on new, lighter materials. Guidant (Indianapolis, Indiana) gained U.S. approval for a significant new stent and <B>Medtronic</B> (Minneapolis, Minnesota) said it has begun a second trial for its Endeavor drug-eluting stent platform.